Crizotinib versus conventional chemotherapy in first-line treatment for ALK-positive non-small cell lung cancer: a systematic review and meta-analysis

Barbara D. Cruz, Mariana M. Barbosa, Lucas L. Torres, Pamela S. Azevedo, Vânia E. A. Silva, Brian Godman, Juliana Alvares-Teodoro

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)
39 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Crizotinib versus conventional chemotherapy in first-line treatment for ALK-positive non-small cell lung cancer: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science